Michael W. Cruise, Ph.D. - Publications

Affiliations: 
2006 University of Virginia, Charlottesville, VA 
Area:
Microbiology Biology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Graham RP, Terracciano LM, Meves A, Vanderboom PM, Dasari S, Yeh MM, Torbenson MS, Cruise MW. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27015136 DOI: 10.1038/modpathol.2016.59  0.92
2014 Wood LD, Salaria SN, Cruise MW, Giardiello FM, Montgomery EA. Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. The American Journal of Surgical Pathology. 38: 389-93. PMID 24525509 DOI: 10.1097/PAS.0000000000000146  0.92
2013 Salaria SN, Abu Alfa AK, Cruise MW, Wood LD, Montgomery EA. Lichenoid esophagitis: clinicopathologic overlap with established esophageal lichen planus. The American Journal of Surgical Pathology. 37: 1889-94. PMID 24061525 DOI: 10.1097/PAS.0b013e31829dff19  0.92
2011 Foo WC, Cruise MW, Wick MR, Hornick JL. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. American Journal of Clinical Pathology. 135: 839-44. PMID 21571956 DOI: 10.1309/Ajcp45Ssnaopxyxu  0.92
2009 Kassel R, Cruise MW, Iezzoni JC, Taylor NA, Pruett TL, Hahn YS. Chronically inflamed livers up-regulate expression of inhibitory B7 family members. Hepatology (Baltimore, Md.). 50: 1625-37. PMID 19739236 DOI: 10.1002/Hep.23173  0.92
2008 Lukens JR, Cruise MW, Lassen MG, Hahn YS. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model. Journal of Immunology (Baltimore, Md. : 1950). 180: 4875-84. PMID 18354211 DOI: 10.4049/Jimmunol.180.7.4875  0.92
2006 Yao ZQ, Waggoner SN, Cruise MW, Hall C, Xie X, Oldach DW, Hahn YS. SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function. Journal of Virology. 80: 8287. PMID 16873288 DOI: 10.1128/JVI.01181-06  0.4
2006 Cruise MW, Lukens JR, Nguyen AP, Lassen MG, Waggoner SN, Hahn YS. Fas ligand is responsible for CXCR3 chemokine induction in CD4+ T cell-dependent liver damage. Journal of Immunology (Baltimore, Md. : 1950). 176: 6235-44. PMID 16670334 DOI: 10.4049/Jimmunol.176.10.6235  0.92
2005 Yao ZQ, Waggoner SN, Cruise MW, Hall C, Xie X, Oldach DW, Hahn YS. SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function. Journal of Virology. 79: 15417-29. PMID 16306613 DOI: 10.1128/Jvi.79.24.15417-15429.2005  0.4
2005 Waggoner SN, Cruise MW, Kassel R, Hahn YS. gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. Journal of Immunology (Baltimore, Md. : 1950). 175: 4706-14. PMID 16177118 DOI: 10.4049/Jimmunol.175.7.4706  0.92
2005 Cruise MW, Melief HM, Lukens J, Soguero C, Hahn YS. Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell-dependent hepatic inflammation. Journal of Leukocyte Biology. 78: 412-25. PMID 15894587 DOI: 10.1189/Jlb.0105005  0.92
Show low-probability matches.